nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—SLC36A1—renal system—colon cancer	0.0159	0.104	CbGeAlD
Vigabatrin—ABAT—renal system—colon cancer	0.0158	0.103	CbGeAlD
Vigabatrin—GABBR1—bone marrow—colon cancer	0.0153	0.0998	CbGeAlD
Vigabatrin—GABBR1—vagina—colon cancer	0.0147	0.0956	CbGeAlD
Vigabatrin—SLC36A1—digestive system—colon cancer	0.013	0.085	CbGeAlD
Vigabatrin—SLC36A1—bone marrow—colon cancer	0.012	0.0784	CbGeAlD
Vigabatrin—SLC36A1—vagina—colon cancer	0.0115	0.0751	CbGeAlD
Vigabatrin—ABAT—vagina—colon cancer	0.0114	0.0746	CbGeAlD
Vigabatrin—SLC36A1—liver—colon cancer	0.00972	0.0633	CbGeAlD
Vigabatrin—ABAT—liver—colon cancer	0.00966	0.0629	CbGeAlD
Vigabatrin—GABBR1—lymph node—colon cancer	0.00949	0.0618	CbGeAlD
Vigabatrin—SLC36A1—lymph node—colon cancer	0.00745	0.0486	CbGeAlD
Vigabatrin—ABAT—lymph node—colon cancer	0.00741	0.0483	CbGeAlD
Vigabatrin—Thirst—Capecitabine—colon cancer	0.00262	0.00309	CcSEcCtD
Vigabatrin—Respiratory failure—Methotrexate—colon cancer	0.0026	0.00307	CcSEcCtD
Vigabatrin—Connective tissue disorder—Vincristine—colon cancer	0.0026	0.00307	CcSEcCtD
Vigabatrin—Purpura—Capecitabine—colon cancer	0.00258	0.00305	CcSEcCtD
Vigabatrin—Sinusitis—Fluorouracil—colon cancer	0.00258	0.00304	CcSEcCtD
Vigabatrin—Pulmonary embolism—Methotrexate—colon cancer	0.00255	0.00302	CcSEcCtD
Vigabatrin—Lethargy—Capecitabine—colon cancer	0.00254	0.003	CcSEcCtD
Vigabatrin—Connective tissue disorder—Irinotecan—colon cancer	0.00253	0.00299	CcSEcCtD
Vigabatrin—Diplopia—Capecitabine—colon cancer	0.00249	0.00294	CcSEcCtD
Vigabatrin—Osteoarthritis—Capecitabine—colon cancer	0.00249	0.00294	CcSEcCtD
Vigabatrin—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00249	0.00294	CcSEcCtD
Vigabatrin—Pain in extremity—Capecitabine—colon cancer	0.00249	0.00294	CcSEcCtD
Vigabatrin—Visual impairment—Irinotecan—colon cancer	0.00248	0.00293	CcSEcCtD
Vigabatrin—Depressed level of consciousness—Methotrexate—colon cancer	0.00247	0.00291	CcSEcCtD
Vigabatrin—Hypoaesthesia—Fluorouracil—colon cancer	0.00245	0.0029	CcSEcCtD
Vigabatrin—Face oedema—Capecitabine—colon cancer	0.0024	0.00284	CcSEcCtD
Vigabatrin—Irritability—Capecitabine—colon cancer	0.00238	0.00281	CcSEcCtD
Vigabatrin—Mood swings—Capecitabine—colon cancer	0.00236	0.00279	CcSEcCtD
Vigabatrin—Ataxia—Capecitabine—colon cancer	0.00234	0.00277	CcSEcCtD
Vigabatrin—Mental disorder—Vincristine—colon cancer	0.00232	0.00273	CcSEcCtD
Vigabatrin—Abdominal pain upper—Capecitabine—colon cancer	0.00227	0.00269	CcSEcCtD
Vigabatrin—Breast disorder—Capecitabine—colon cancer	0.00225	0.00266	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00224	0.00265	CcSEcCtD
Vigabatrin—Nasopharyngitis—Capecitabine—colon cancer	0.00223	0.00263	CcSEcCtD
Vigabatrin—Back pain—Vincristine—colon cancer	0.00223	0.00263	CcSEcCtD
Vigabatrin—Back pain—Irinotecan—colon cancer	0.00217	0.00256	CcSEcCtD
Vigabatrin—Abdominal distension—Capecitabine—colon cancer	0.00217	0.00256	CcSEcCtD
Vigabatrin—Muscle spasms—Irinotecan—colon cancer	0.00215	0.00254	CcSEcCtD
Vigabatrin—Influenza—Capecitabine—colon cancer	0.00215	0.00254	CcSEcCtD
Vigabatrin—Anaemia—Vincristine—colon cancer	0.00213	0.00251	CcSEcCtD
Vigabatrin—Agitation—Vincristine—colon cancer	0.00211	0.0025	CcSEcCtD
Vigabatrin—Ill-defined disorder—Irinotecan—colon cancer	0.00208	0.00246	CcSEcCtD
Vigabatrin—Anaemia—Irinotecan—colon cancer	0.00207	0.00245	CcSEcCtD
Vigabatrin—Bronchitis—Capecitabine—colon cancer	0.00207	0.00244	CcSEcCtD
Vigabatrin—Vertigo—Vincristine—colon cancer	0.00207	0.00244	CcSEcCtD
Vigabatrin—Abdominal discomfort—Capecitabine—colon cancer	0.00206	0.00244	CcSEcCtD
Vigabatrin—Vision blurred—Fluorouracil—colon cancer	0.00202	0.00239	CcSEcCtD
Vigabatrin—Malaise—Irinotecan—colon cancer	0.00202	0.00239	CcSEcCtD
Vigabatrin—Vertigo—Irinotecan—colon cancer	0.00201	0.00238	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Capecitabine—colon cancer	0.002	0.00236	CcSEcCtD
Vigabatrin—Convulsion—Vincristine—colon cancer	0.00199	0.00235	CcSEcCtD
Vigabatrin—Anaemia—Fluorouracil—colon cancer	0.00198	0.00234	CcSEcCtD
Vigabatrin—Myalgia—Vincristine—colon cancer	0.00196	0.00231	CcSEcCtD
Vigabatrin—Weight increased—Capecitabine—colon cancer	0.00196	0.00231	CcSEcCtD
Vigabatrin—Cough—Irinotecan—colon cancer	0.00195	0.00231	CcSEcCtD
Vigabatrin—Pneumonia—Capecitabine—colon cancer	0.00193	0.00228	CcSEcCtD
Vigabatrin—Infestation NOS—Capecitabine—colon cancer	0.00192	0.00227	CcSEcCtD
Vigabatrin—Infestation—Capecitabine—colon cancer	0.00192	0.00227	CcSEcCtD
Vigabatrin—Depression—Capecitabine—colon cancer	0.00191	0.00226	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.0019	0.00225	CcSEcCtD
Vigabatrin—Lethargy—Methotrexate—colon cancer	0.00189	0.00223	CcSEcCtD
Vigabatrin—Discomfort—Irinotecan—colon cancer	0.00188	0.00223	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Capecitabine—colon cancer	0.00188	0.00222	CcSEcCtD
Vigabatrin—Oedema—Vincristine—colon cancer	0.00188	0.00222	CcSEcCtD
Vigabatrin—Infection—Vincristine—colon cancer	0.00187	0.0022	CcSEcCtD
Vigabatrin—Urinary tract infection—Capecitabine—colon cancer	0.00187	0.0022	CcSEcCtD
Vigabatrin—Conjunctivitis—Capecitabine—colon cancer	0.00187	0.0022	CcSEcCtD
Vigabatrin—Convulsion—Fluorouracil—colon cancer	0.00186	0.0022	CcSEcCtD
Vigabatrin—Osteoarthritis—Methotrexate—colon cancer	0.00185	0.00219	CcSEcCtD
Vigabatrin—Confusional state—Irinotecan—colon cancer	0.00184	0.00218	CcSEcCtD
Vigabatrin—Nervous system disorder—Vincristine—colon cancer	0.00184	0.00217	CcSEcCtD
Vigabatrin—Oedema—Irinotecan—colon cancer	0.00183	0.00216	CcSEcCtD
Vigabatrin—Chest pain—Fluorouracil—colon cancer	0.00183	0.00216	CcSEcCtD
Vigabatrin—Myalgia—Fluorouracil—colon cancer	0.00183	0.00216	CcSEcCtD
Vigabatrin—Infection—Irinotecan—colon cancer	0.00182	0.00215	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Capecitabine—colon cancer	0.00181	0.00214	CcSEcCtD
Vigabatrin—Discomfort—Fluorouracil—colon cancer	0.0018	0.00213	CcSEcCtD
Vigabatrin—Nervous system disorder—Irinotecan—colon cancer	0.00179	0.00212	CcSEcCtD
Vigabatrin—Irritability—Methotrexate—colon cancer	0.00177	0.00209	CcSEcCtD
Vigabatrin—Confusional state—Fluorouracil—colon cancer	0.00177	0.00209	CcSEcCtD
Vigabatrin—Mood swings—Methotrexate—colon cancer	0.00176	0.00207	CcSEcCtD
Vigabatrin—Oedema—Fluorouracil—colon cancer	0.00175	0.00207	CcSEcCtD
Vigabatrin—Ataxia—Methotrexate—colon cancer	0.00174	0.00206	CcSEcCtD
Vigabatrin—Infection—Fluorouracil—colon cancer	0.00174	0.00206	CcSEcCtD
Vigabatrin—Nervous system disorder—Fluorouracil—colon cancer	0.00172	0.00203	CcSEcCtD
Vigabatrin—Hypoaesthesia—Capecitabine—colon cancer	0.00171	0.00202	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Vincristine—colon cancer	0.00171	0.00202	CcSEcCtD
Vigabatrin—Insomnia—Vincristine—colon cancer	0.0017	0.00201	CcSEcCtD
Vigabatrin—Oedema peripheral—Capecitabine—colon cancer	0.0017	0.002	CcSEcCtD
Vigabatrin—Connective tissue disorder—Capecitabine—colon cancer	0.00169	0.002	CcSEcCtD
Vigabatrin—Paraesthesia—Vincristine—colon cancer	0.00169	0.00199	CcSEcCtD
Vigabatrin—Breast disorder—Methotrexate—colon cancer	0.00167	0.00198	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00167	0.00197	CcSEcCtD
Vigabatrin—Visual impairment—Capecitabine—colon cancer	0.00166	0.00196	CcSEcCtD
Vigabatrin—Insomnia—Irinotecan—colon cancer	0.00165	0.00195	CcSEcCtD
Vigabatrin—Paraesthesia—Irinotecan—colon cancer	0.00164	0.00194	CcSEcCtD
Vigabatrin—Decreased appetite—Vincristine—colon cancer	0.00163	0.00193	CcSEcCtD
Vigabatrin—Erythema multiforme—Capecitabine—colon cancer	0.00163	0.00192	CcSEcCtD
Vigabatrin—Somnolence—Irinotecan—colon cancer	0.00163	0.00192	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Vincristine—colon cancer	0.00162	0.00191	CcSEcCtD
Vigabatrin—Fatigue—Vincristine—colon cancer	0.00162	0.00191	CcSEcCtD
Vigabatrin—Eye disorder—Capecitabine—colon cancer	0.00161	0.0019	CcSEcCtD
Vigabatrin—Dyspepsia—Irinotecan—colon cancer	0.00161	0.0019	CcSEcCtD
Vigabatrin—Tinnitus—Capecitabine—colon cancer	0.00161	0.0019	CcSEcCtD
Vigabatrin—Pain—Vincristine—colon cancer	0.00161	0.0019	CcSEcCtD
Vigabatrin—Constipation—Vincristine—colon cancer	0.00161	0.0019	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0016	0.00188	CcSEcCtD
Vigabatrin—Decreased appetite—Irinotecan—colon cancer	0.00159	0.00188	CcSEcCtD
Vigabatrin—Insomnia—Fluorouracil—colon cancer	0.00158	0.00187	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Irinotecan—colon cancer	0.00158	0.00186	CcSEcCtD
Vigabatrin—Fatigue—Irinotecan—colon cancer	0.00158	0.00186	CcSEcCtD
Vigabatrin—Paraesthesia—Fluorouracil—colon cancer	0.00157	0.00186	CcSEcCtD
Vigabatrin—Pain—Irinotecan—colon cancer	0.00156	0.00185	CcSEcCtD
Vigabatrin—Constipation—Irinotecan—colon cancer	0.00156	0.00185	CcSEcCtD
Vigabatrin—Somnolence—Fluorouracil—colon cancer	0.00156	0.00184	CcSEcCtD
Vigabatrin—Dyspepsia—Fluorouracil—colon cancer	0.00154	0.00182	CcSEcCtD
Vigabatrin—Abdominal discomfort—Methotrexate—colon cancer	0.00154	0.00181	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Vincristine—colon cancer	0.00154	0.00181	CcSEcCtD
Vigabatrin—Decreased appetite—Fluorouracil—colon cancer	0.00152	0.0018	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00151	0.00179	CcSEcCtD
Vigabatrin—Mental disorder—Capecitabine—colon cancer	0.00151	0.00178	CcSEcCtD
Vigabatrin—Feeling abnormal—Irinotecan—colon cancer	0.00151	0.00178	CcSEcCtD
Vigabatrin—Malnutrition—Capecitabine—colon cancer	0.0015	0.00177	CcSEcCtD
Vigabatrin—Pain—Fluorouracil—colon cancer	0.0015	0.00177	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Irinotecan—colon cancer	0.0015	0.00177	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Methotrexate—colon cancer	0.00149	0.00176	CcSEcCtD
Vigabatrin—Body temperature increased—Vincristine—colon cancer	0.00148	0.00175	CcSEcCtD
Vigabatrin—Abdominal pain—Vincristine—colon cancer	0.00148	0.00175	CcSEcCtD
Vigabatrin—Erectile dysfunction—Methotrexate—colon cancer	0.00148	0.00174	CcSEcCtD
Vigabatrin—Back pain—Capecitabine—colon cancer	0.00145	0.00171	CcSEcCtD
Vigabatrin—Body temperature increased—Irinotecan—colon cancer	0.00145	0.00171	CcSEcCtD
Vigabatrin—Abdominal pain—Irinotecan—colon cancer	0.00145	0.00171	CcSEcCtD
Vigabatrin—Feeling abnormal—Fluorouracil—colon cancer	0.00144	0.0017	CcSEcCtD
Vigabatrin—Muscle spasms—Capecitabine—colon cancer	0.00144	0.0017	CcSEcCtD
Vigabatrin—Pneumonia—Methotrexate—colon cancer	0.00144	0.0017	CcSEcCtD
Vigabatrin—Drowsiness—Methotrexate—colon cancer	0.00143	0.00169	CcSEcCtD
Vigabatrin—Infestation—Methotrexate—colon cancer	0.00143	0.00169	CcSEcCtD
Vigabatrin—Infestation NOS—Methotrexate—colon cancer	0.00143	0.00169	CcSEcCtD
Vigabatrin—Depression—Methotrexate—colon cancer	0.00142	0.00168	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00142	0.00167	CcSEcCtD
Vigabatrin—Vision blurred—Capecitabine—colon cancer	0.00141	0.00167	CcSEcCtD
Vigabatrin—Tremor—Capecitabine—colon cancer	0.0014	0.00166	CcSEcCtD
Vigabatrin—Ill-defined disorder—Capecitabine—colon cancer	0.00139	0.00164	CcSEcCtD
Vigabatrin—Urticaria—Fluorouracil—colon cancer	0.00139	0.00164	CcSEcCtD
Vigabatrin—Conjunctivitis—Methotrexate—colon cancer	0.00139	0.00164	CcSEcCtD
Vigabatrin—Anaemia—Capecitabine—colon cancer	0.00139	0.00164	CcSEcCtD
Vigabatrin—Body temperature increased—Fluorouracil—colon cancer	0.00138	0.00164	CcSEcCtD
Vigabatrin—Hypersensitivity—Vincristine—colon cancer	0.00138	0.00163	CcSEcCtD
Vigabatrin—Malaise—Capecitabine—colon cancer	0.00135	0.0016	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Methotrexate—colon cancer	0.00135	0.0016	CcSEcCtD
Vigabatrin—Vertigo—Capecitabine—colon cancer	0.00135	0.00159	CcSEcCtD
Vigabatrin—Hypersensitivity—Irinotecan—colon cancer	0.00135	0.00159	CcSEcCtD
Vigabatrin—Asthenia—Vincristine—colon cancer	0.00135	0.00159	CcSEcCtD
Vigabatrin—Asthenia—Irinotecan—colon cancer	0.00131	0.00155	CcSEcCtD
Vigabatrin—Cough—Capecitabine—colon cancer	0.00131	0.00155	CcSEcCtD
Vigabatrin—Hypersensitivity—Fluorouracil—colon cancer	0.00129	0.00152	CcSEcCtD
Vigabatrin—Diarrhoea—Vincristine—colon cancer	0.00128	0.00152	CcSEcCtD
Vigabatrin—Chest pain—Capecitabine—colon cancer	0.00128	0.00151	CcSEcCtD
Vigabatrin—Myalgia—Capecitabine—colon cancer	0.00128	0.00151	CcSEcCtD
Vigabatrin—Arthralgia—Capecitabine—colon cancer	0.00128	0.00151	CcSEcCtD
Vigabatrin—Anxiety—Capecitabine—colon cancer	0.00127	0.0015	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00127	0.0015	CcSEcCtD
Vigabatrin—Discomfort—Capecitabine—colon cancer	0.00126	0.00149	CcSEcCtD
Vigabatrin—Diarrhoea—Irinotecan—colon cancer	0.00125	0.00148	CcSEcCtD
Vigabatrin—Dizziness—Vincristine—colon cancer	0.00124	0.00147	CcSEcCtD
Vigabatrin—Pruritus—Fluorouracil—colon cancer	0.00124	0.00146	CcSEcCtD
Vigabatrin—Visual impairment—Methotrexate—colon cancer	0.00124	0.00146	CcSEcCtD
Vigabatrin—Confusional state—Capecitabine—colon cancer	0.00123	0.00146	CcSEcCtD
Vigabatrin—Oedema—Capecitabine—colon cancer	0.00122	0.00145	CcSEcCtD
Vigabatrin—Infection—Capecitabine—colon cancer	0.00122	0.00144	CcSEcCtD
Vigabatrin—Erythema multiforme—Methotrexate—colon cancer	0.00121	0.00143	CcSEcCtD
Vigabatrin—Dizziness—Irinotecan—colon cancer	0.00121	0.00143	CcSEcCtD
Vigabatrin—Nervous system disorder—Capecitabine—colon cancer	0.0012	0.00142	CcSEcCtD
Vigabatrin—Eye disorder—Methotrexate—colon cancer	0.0012	0.00142	CcSEcCtD
Vigabatrin—Diarrhoea—Fluorouracil—colon cancer	0.0012	0.00142	CcSEcCtD
Vigabatrin—Tinnitus—Methotrexate—colon cancer	0.0012	0.00141	CcSEcCtD
Vigabatrin—Vomiting—Vincristine—colon cancer	0.00119	0.00141	CcSEcCtD
Vigabatrin—Skin disorder—Capecitabine—colon cancer	0.00119	0.0014	CcSEcCtD
Vigabatrin—Rash—Vincristine—colon cancer	0.00118	0.0014	CcSEcCtD
Vigabatrin—Dermatitis—Vincristine—colon cancer	0.00118	0.0014	CcSEcCtD
Vigabatrin—Headache—Vincristine—colon cancer	0.00118	0.00139	CcSEcCtD
Vigabatrin—Vomiting—Irinotecan—colon cancer	0.00116	0.00137	CcSEcCtD
Vigabatrin—Dizziness—Fluorouracil—colon cancer	0.00116	0.00137	CcSEcCtD
Vigabatrin—Rash—Irinotecan—colon cancer	0.00115	0.00136	CcSEcCtD
Vigabatrin—Dermatitis—Irinotecan—colon cancer	0.00115	0.00136	CcSEcCtD
Vigabatrin—Headache—Irinotecan—colon cancer	0.00115	0.00135	CcSEcCtD
Vigabatrin—Mental disorder—Methotrexate—colon cancer	0.00112	0.00133	CcSEcCtD
Vigabatrin—Malnutrition—Methotrexate—colon cancer	0.00112	0.00132	CcSEcCtD
Vigabatrin—Nausea—Vincristine—colon cancer	0.00112	0.00132	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00111	0.00132	CcSEcCtD
Vigabatrin—Vomiting—Fluorouracil—colon cancer	0.00111	0.00132	CcSEcCtD
Vigabatrin—Insomnia—Capecitabine—colon cancer	0.00111	0.00131	CcSEcCtD
Vigabatrin—Rash—Fluorouracil—colon cancer	0.0011	0.0013	CcSEcCtD
Vigabatrin—Dermatitis—Fluorouracil—colon cancer	0.0011	0.0013	CcSEcCtD
Vigabatrin—Paraesthesia—Capecitabine—colon cancer	0.0011	0.0013	CcSEcCtD
Vigabatrin—Headache—Fluorouracil—colon cancer	0.0011	0.0013	CcSEcCtD
Vigabatrin—Nausea—Irinotecan—colon cancer	0.00109	0.00128	CcSEcCtD
Vigabatrin—Back pain—Methotrexate—colon cancer	0.00108	0.00128	CcSEcCtD
Vigabatrin—Dyspepsia—Capecitabine—colon cancer	0.00108	0.00127	CcSEcCtD
Vigabatrin—Decreased appetite—Capecitabine—colon cancer	0.00106	0.00126	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Capecitabine—colon cancer	0.00106	0.00125	CcSEcCtD
Vigabatrin—Fatigue—Capecitabine—colon cancer	0.00106	0.00125	CcSEcCtD
Vigabatrin—Vision blurred—Methotrexate—colon cancer	0.00105	0.00124	CcSEcCtD
Vigabatrin—Pain—Capecitabine—colon cancer	0.00105	0.00124	CcSEcCtD
Vigabatrin—Constipation—Capecitabine—colon cancer	0.00105	0.00124	CcSEcCtD
Vigabatrin—Nausea—Fluorouracil—colon cancer	0.00104	0.00123	CcSEcCtD
Vigabatrin—Ill-defined disorder—Methotrexate—colon cancer	0.00104	0.00122	CcSEcCtD
Vigabatrin—Anaemia—Methotrexate—colon cancer	0.00103	0.00122	CcSEcCtD
Vigabatrin—Feeling abnormal—Capecitabine—colon cancer	0.00101	0.00119	CcSEcCtD
Vigabatrin—Malaise—Methotrexate—colon cancer	0.00101	0.00119	CcSEcCtD
Vigabatrin—Vertigo—Methotrexate—colon cancer	0.001	0.00118	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Capecitabine—colon cancer	0.001	0.00118	CcSEcCtD
Vigabatrin—Cough—Methotrexate—colon cancer	0.000974	0.00115	CcSEcCtD
Vigabatrin—Urticaria—Capecitabine—colon cancer	0.000972	0.00115	CcSEcCtD
Vigabatrin—Abdominal pain—Capecitabine—colon cancer	0.000967	0.00114	CcSEcCtD
Vigabatrin—Body temperature increased—Capecitabine—colon cancer	0.000967	0.00114	CcSEcCtD
Vigabatrin—Convulsion—Methotrexate—colon cancer	0.000967	0.00114	CcSEcCtD
Vigabatrin—Chest pain—Methotrexate—colon cancer	0.00095	0.00112	CcSEcCtD
Vigabatrin—Arthralgia—Methotrexate—colon cancer	0.00095	0.00112	CcSEcCtD
Vigabatrin—Myalgia—Methotrexate—colon cancer	0.00095	0.00112	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000944	0.00111	CcSEcCtD
Vigabatrin—Discomfort—Methotrexate—colon cancer	0.000939	0.00111	CcSEcCtD
Vigabatrin—Confusional state—Methotrexate—colon cancer	0.000919	0.00109	CcSEcCtD
Vigabatrin—Infection—Methotrexate—colon cancer	0.000905	0.00107	CcSEcCtD
Vigabatrin—Hypersensitivity—Capecitabine—colon cancer	0.000902	0.00107	CcSEcCtD
Vigabatrin—Nervous system disorder—Methotrexate—colon cancer	0.000893	0.00106	CcSEcCtD
Vigabatrin—Skin disorder—Methotrexate—colon cancer	0.000885	0.00105	CcSEcCtD
Vigabatrin—Asthenia—Capecitabine—colon cancer	0.000878	0.00104	CcSEcCtD
Vigabatrin—Pruritus—Capecitabine—colon cancer	0.000866	0.00102	CcSEcCtD
Vigabatrin—Diarrhoea—Capecitabine—colon cancer	0.000837	0.000989	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00083	0.00098	CcSEcCtD
Vigabatrin—Insomnia—Methotrexate—colon cancer	0.000824	0.000973	CcSEcCtD
Vigabatrin—Paraesthesia—Methotrexate—colon cancer	0.000818	0.000966	CcSEcCtD
Vigabatrin—Somnolence—Methotrexate—colon cancer	0.00081	0.000957	CcSEcCtD
Vigabatrin—Dizziness—Capecitabine—colon cancer	0.000809	0.000956	CcSEcCtD
Vigabatrin—Dyspepsia—Methotrexate—colon cancer	0.000802	0.000947	CcSEcCtD
Vigabatrin—Decreased appetite—Methotrexate—colon cancer	0.000792	0.000935	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000786	0.000929	CcSEcCtD
Vigabatrin—Fatigue—Methotrexate—colon cancer	0.000785	0.000928	CcSEcCtD
Vigabatrin—Pain—Methotrexate—colon cancer	0.000779	0.00092	CcSEcCtD
Vigabatrin—Vomiting—Capecitabine—colon cancer	0.000778	0.000919	CcSEcCtD
Vigabatrin—Rash—Capecitabine—colon cancer	0.000772	0.000911	CcSEcCtD
Vigabatrin—Dermatitis—Capecitabine—colon cancer	0.000771	0.000911	CcSEcCtD
Vigabatrin—Headache—Capecitabine—colon cancer	0.000767	0.000906	CcSEcCtD
Vigabatrin—Feeling abnormal—Methotrexate—colon cancer	0.000751	0.000887	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methotrexate—colon cancer	0.000745	0.00088	CcSEcCtD
Vigabatrin—Nausea—Capecitabine—colon cancer	0.000727	0.000859	CcSEcCtD
Vigabatrin—Urticaria—Methotrexate—colon cancer	0.000724	0.000855	CcSEcCtD
Vigabatrin—Body temperature increased—Methotrexate—colon cancer	0.00072	0.000851	CcSEcCtD
Vigabatrin—Abdominal pain—Methotrexate—colon cancer	0.00072	0.000851	CcSEcCtD
Vigabatrin—Hypersensitivity—Methotrexate—colon cancer	0.000671	0.000793	CcSEcCtD
Vigabatrin—Asthenia—Methotrexate—colon cancer	0.000654	0.000772	CcSEcCtD
Vigabatrin—Pruritus—Methotrexate—colon cancer	0.000645	0.000761	CcSEcCtD
Vigabatrin—Diarrhoea—Methotrexate—colon cancer	0.000623	0.000736	CcSEcCtD
Vigabatrin—Dizziness—Methotrexate—colon cancer	0.000602	0.000712	CcSEcCtD
Vigabatrin—Vomiting—Methotrexate—colon cancer	0.000579	0.000684	CcSEcCtD
Vigabatrin—Rash—Methotrexate—colon cancer	0.000574	0.000679	CcSEcCtD
Vigabatrin—Dermatitis—Methotrexate—colon cancer	0.000574	0.000678	CcSEcCtD
Vigabatrin—Headache—Methotrexate—colon cancer	0.000571	0.000674	CcSEcCtD
Vigabatrin—Nausea—Methotrexate—colon cancer	0.000541	0.000639	CcSEcCtD
